Dr. D. B. Sarkar Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 05-12-2024
- Paid Up Capital ₹ 3.00 M
as on 05-12-2024
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.49 M
as on 05-12-2024
- Revenue 3.40%
(FY 2020)
- Profit 6.03%
(FY 2020)
- Ebitda 38.24%
(FY 2020)
- Net Worth 5.71%
(FY 2020)
- Total Assets -6.58%
(FY 2020)
About Dr. D. B. Sarkar Eye Hospital
The Corporate was formerly known as Coochbehar Eyecare And Research Centre Pvt Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹9.49 M.
Dwija Sarkar and Suchismita Sarkar serve as directors at the Company.
- CIN/LLPIN
U85195WB1995PTC072736
- Company No.
072736
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Cooch Behar, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. D. B. Sarkar Eye Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dwija Sarkar  | Director | 07-Jul-1995 | Current |
| Suchismita Sarkar | Director | 15-Mar-2013 | Current |
Financial Performance of Dr. D. B. Sarkar Eye Hospital.
Dr. D. B. Sarkar Eye Hospital Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.4% increase. The company also saw a slight improvement in profitability, with a 6.03% increase in profit. The company's net worth moved up by a moderate rise of 5.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. D. B. Sarkar Eye Hospital?
In 2019, Dr. D. B. Sarkar Eye Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.49 M
₹0
Charges Breakdown by Lending Institutions
- United Bank Of India : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2011 | United Bank Of India | ₹2.49 M | Open |
| 15 Sep 2003 | United Bank Of India | ₹7.00 M | Open |
How Many Employees Work at Dr. D. B. Sarkar Eye Hospital?
Dr. D. B. Sarkar Eye Hospital has a workforce of 15 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. D. B. Sarkar Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. D. B. Sarkar Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
